Cogent Biosciences (COGT) Times Interest Earned (2025 - 2026)

Cogent Biosciences (COGT) recorded quarterly Times Interest Earned of -$85.41 in Q1 2026, down 10.66% quarter-over-quarter from -$77.19 in Q4 2025.

Cogent Biosciences (COGT) Times Interest Earned (2025 - 2026) Analysis & Trends

Cogent Biosciences' Times Interest Earned history runs 2 years deep, the most recent figure standing at -$85.41 for Q1 2026.

In Q1 2026, Times Interest Earned changed N/A year-over-year to -$85.41; the TTM figure through Mar 2026 stood at -$84.69 (changed N/A YoY), while the FY2025 annual figure was -$108.87, changed N/A from the prior year.
Times Interest Earned was -$85.41 for Q1 2026 at Cogent Biosciences, down from -$77.19 in the prior quarter.
In the past five years, Times Interest Earned ranged from a high of -$57.13 in Q3 2025 to a low of -$240.71 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	3.58
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-258.33
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	11.50
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	547.67
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-
9	Abivax	91.71 Bn	91.71 Bn	-	11.79
10	Cogent Biosciences	5.09 Bn	4.22 Bn	-	-85.41

Download Data